User profiles for "author:Marie Kroemer"
Marie KroemerPharmD, PhD - Université de Bourgogne Franche-Comté Verified email at chu-besancon.fr Cited by 362 |
[HTML][HTML] Epigenetic Reprogramming of CD4+ Helper T Cells as a Strategy to Improve Anticancer Immunotherapy
E Renaude, M Kroemer, C Borg, P Peixoto… - Frontiers in …, 2021 - frontiersin.org
Evidences highlight the role of various CD4+ helper T cells (CD4+ Th) subpopulations in
orchestrating the immune responses against cancers. Epigenetics takes an important part in …
orchestrating the immune responses against cancers. Epigenetics takes an important part in …
[HTML][HTML] The fate of Th17 cells is shaped by epigenetic modifications and remodeled by the tumor microenvironment
E Renaude, M Kroemer, R Loyon, D Binda… - International journal of …, 2020 - mdpi.com
Th17 cells represent a subset of CD4+ T cells characterized by the master transcription
factor RORγt and the production of IL-17. Epigenetic modifications such as post-translational …
factor RORγt and the production of IL-17. Epigenetic modifications such as post-translational …
[HTML][HTML] Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment
A Gomez-Cadena, L Spehner, M Kroemer… - Cellular & Molecular …, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
current COVID-19 disease pandemic. In some patients, the symptoms are mild, and a …
current COVID-19 disease pandemic. In some patients, the symptoms are mild, and a …
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
M Kroemer, L Spehner, L Vettoretti, A Bouard… - Journal of Infection, 2021 - Elsevier
Adaptive Immune responses generated by SARS-CoV-2 virus in convalescent patients
according to disease severity remain poorly characterized. To this end, we designed a …
according to disease severity remain poorly characterized. To this end, we designed a …
Safety, immunogenicity, and 1-year efficacy of universal cancer peptide–based vaccine in patients with refractory advanced non–small-cell lung cancer: a phase Ib …
O Adotévi, D Vernerey, P Jacoulet… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE Universal cancer peptide–based vaccine (UCPVax) is a therapeutic vaccine
composed of two highly selected helper peptides to induce CD4+ T helper-1 response …
composed of two highly selected helper peptides to induce CD4+ T helper-1 response …
[HTML][HTML] Peripheral innate lymphoid cells are increased in first line metastatic colorectal carcinoma patients: a negative correlation with Th1 immune responses
R Loyon, M Jary, B Salomé, A Gomez-Cadena… - Frontiers in …, 2019 - frontiersin.org
Several distinct innate lymphoid cell (ILC) populations have been recently identified and
shown to play a critical role in the immediate immune defense. In the context of tumors, there …
shown to play a critical role in the immediate immune defense. In the context of tumors, there …
[HTML][HTML] Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases
M Kroemer, C Turco, L Spehner, J Viot… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background The positive role of CD8+ tumor-infiltrating lymphocytes (TIL) in patients with
colorectal cancer (CRC) has been well described but the prognostic value of CD4 T cell …
colorectal cancer (CRC) has been well described but the prognostic value of CD4 T cell …
Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapy
A Vienot, JR Pallandre, E Renaude, J Viot… - …, 2022 - Taylor & Francis
Combining immunogenic cell death-inducing chemotherapies and PD-1 blockade can
generate remarkable tumor responses. It is now well established that TGF-β1 signaling is a …
generate remarkable tumor responses. It is now well established that TGF-β1 signaling is a …
[HTML][HTML] Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?
S Abdeljaoued, S Arfa, M Kroemer… - … for Immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Tissue-resident memory T (T RM) cells have emerged as immune sentinels that patrol the
tissue microenvironment and orchestrate localized antitumor immunity in various solid …
tissue microenvironment and orchestrate localized antitumor immunity in various solid …
[HTML][HTML] CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery
J Viot, S Abdeljaoued, A Vienot, E Seffar… - Cellular & molecular …, 2023 - nature.com
CD226 has been reported to participate in the rescue of CD8+ T cell dysfunction. In this
study, we aimed to assess the prognostic value of CD226 in tumor-infiltrating lymphocytes …
study, we aimed to assess the prognostic value of CD226 in tumor-infiltrating lymphocytes …